Abstract
Telomeres are DNA sequence that are repeated at the end of the linear chromosomes and ensure chromosome stability during replication. Telomere length shortened each cell division and during oxidative stress. When telomeres lose their length critically, cell division can no longer occur which causes cells to enter senescence. Besides, telomeres are sensitive to oxidative stress which can cause telomere shortening. Telomerase, which consists of a structural RNA and two proteins, is a cellular reverse transcriptase. This reverse transcriptase adds new DNA onto the telomeres and thus it is responsible for telomere length. There is no telomerase activity in human somatic cells due to the lack of the human telomerase reverse transcriptase (hTERT) expression; because of this situation, telomeres progressively shortened and finally exhausted with aging process. Telomerase activation is a potentially helpful technique for anti-aging strategy and to combat age-related diseases. Telomerase activators that are chemical molecules activate telomerase, or hTERT is used as an antiaging supplement that is a new era of antiaging nutritional science. This chapter has discussed antiaging strategies based on telomerase activity to combat the aging process.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adelfalk C, Lorenz M, Serra V et al (2001) Accelerated telomere shortening in Fanconi anemia fibroblasts – a longitudinal study. FEBS Lett 506:22–26
Ahmed A, Tollefsbol T (2001) Telomeres and telomerase: basic science implications for aging. J Am Geriatr Soc 49:1105–1109
Aubert G, Lansdorp PM (2008) Telomeres and aging. Physiol Rev 88:557–579
Bär C, Povedano JM, Serrano R et al (2016) Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia. Blood 127:1770–1779
Batista LF (2014) Telomere biology in stem cells and reprogramming. Prog Mol Biol Transl Sci 125:67–88
Bayne S, Jones MEE, Li H et al (2008) Estrogen deficiency leads to telomerase inhibition, telomere shortening and reduced cell proliferation in the adrenal gland of mice. Cell Res 18:1141–1150
Bernardes de Jesus B, Schneeberger K, Vera E et al (2011) The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence. Aging Cell 10:604–621
Bernardes de Jesus B, Vera E, Schneeberger K et al (2012) Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol Med 4:691–704. https://doi.org/10.1002/emmm.201200245
Blackburn EH (1990) Telomeres: structure and synthesis. J Biol Chem 265:5919–5921
Blackburn EH (1991) Structure and function of telomeres. Nature 350:569–573
Blackburn EH, Collins K (2011) Telomerase: an RNP enzyme synthesizes DNA. Cold Spring Harb Perspect Biol 3(5). pii: a003558. https://doi.org/10.1101/cshperspect.a003558
Blasco MA, Lee HW, Rizen M et al (1997) Mouse models for the study of telomerase. CIBA Found Symp 211:160–170
Bodnar AG, Ouellette M, Frolkis M et al (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279:349–352
Calado RT, Yewdell WT, Wilkerson KL et al (2009) Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood 114:2236–2243
Cawthon RM, Smith KR, O’Brien E et al (2003) Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361:393–395
Celli GB, de Lange T (2005) DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat Cell Biol 7:712–718
Chau MN, El Touny LH, Jagadeesh S et al (2007) Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3. Carcinogenesis 28:2282–2290
Chen Q, Fischer A, Reagan JD et al (1995) Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci U S A 92:4337–4341
Cohen SB, Graham ME, Lovrecz GO et al (2007) Protein composition of catalytically active human telomerase from immortal cells. Science 315:1850–1853
Cong YS, Wright WE, Shay JW (2002) Human telomerase and its regulation. Microbiol Mol Biol Rev 66:407–425
Counter CM, Gupta J, Harley CB et al (1995) Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85:2315–2320
Cristofari G, Adolf E, Reichenbach P et al (2007) Human telomerase RNA accumulation in Cajal bodies facilitates telomerase recruitment to telomeres and telomere elongation. Mol Cell 27:882–889
Darimont C et al (2002) SV40 T antigen and telomerase are required to obtain immortalized human adult bone cells without loss of the differentiated phenotype. Cell Growth Differ 13:59–67
De Lange T (2005) Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19:2100–2110
Djojosubroto MW, Choi YS, Lee HW et al (2003) Telomeres and telomerase in aging, regeneration and cancer. Mol Cell 15:164–175
Dock JN, Effros RB (2011) Role of CD8 T cell replicative senescence in human aging and in HIV-mediated Immunosenescence. Aging Dis 2:382–397
Dong XX, Hui ZJ, Xiang WX et al (2007) Ginkgo biloba extract reduces endothelial progenitor-cell senescence through augmentation of telomerase activity. J Cardiovasc Pharmacol 49:111–115
Doshida M, Ohmichi M, Tsutsumi S et al (2006) Raloxifene increases proliferation and up-regulates telomerase activity in human umbilical vein endothelial cells. J Biol Chem 281:24270–24278
Dow CT, Harley CB (2016) Evaluation of an oral telomerase activator for early age-related macular degeneration – a pilot study. Clin Ophthalmol 10:243–249
Eitan E, Tichon A, Gazit A et al (2012) Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis. EMBO Mol Med 4:313–329
Farzaneh-Far R, Lin J, Epel ES et al (2010) Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA 303:250–257
Gonzalez-Giraldo Y, Forero DA, Echeverria V et al (2016) Neuroprotective effects of the catalytic subunit of telomerase: a potential therapeutic target in the central nervous system. Ageing Res Rev 28:37–45
Gonzalez-Suarez E, Samper E, Ramirez A et al (2001) Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J 20:2619–2630
Gonzalez-Suarez E, Geserick C, Flores JM et al (2005) Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice. Oncogene 24:2256–2270
Greider CW, Blackburn EH (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43:405–413
Greider CW, Blackburn EH (1987) The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51:887–898
Griffith JD, Comeau L, Rosenfield S et al (1999) Mammalian telomeres end in a large duplex loop. Cell 97:503–514
Haendeler J, Hoffmann J, Brandes RP et al (2003) Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol Cell Biol 23:4598–4610
Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA (1999) Creation of human tumour cells with defined genetic elements. Nature 400(6743):464–468
Harley CB, Villeponteau B (1995) Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 5:249–255
Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345:458–460
Harley CB, Kim NW, Prowse KR et al (1994) Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 59:307–315
Harley CB, Liu W, Blasco M et al (2011) A natural product telomerase activator as part of a health maintenance program. Rejuvenation Res 14:45–56
Harley CB, Liu W, Flom PL et al (2013) A natural product telomerase activator as part of a health maintenance program: metabolic and cardiovascular response. Rejuvenation Res 16:386–395
Hayflick L (1965) The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37:614–636
Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25:585–621
Hiyama K et al (1995) Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155:3711–3715
Hockemeyer D, Palm W, Else T et al (2007) Telomere protection by mammalian Pot1 requires interaction with Tpp1. Nat Struct Mol Biol 14:754–761
Holt SE, Aisner DL, Baur J et al (1999) Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev 13:817–826
Jady BE, Richard P, Bertrand E et al (2006) Cell cycle-dependent recruitment of telomerase RNA and Cajal bodies to human telomeres. Mol Biol Cell 17:944–954
Jaskelioff M, Muller FL, Paik JH et al (2011) Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 469:102–106
Kim NW, Piatyszek MA, Prowse KR et al (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015
Kim SH, Kaminker P, Campisi J (1999) TIN2, a new regulator of telomere length in human cells. Nat Genet 23:405–412
Klinger RY, Blum JL, Hearn B et al (2006) Relevance and safety of telomerase for human tissue engineering. Proc Natl Acad Sci U S A 103:2500–2505
Le Saux CJ, Davy P, Brampton C et al (2013) A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis. PLoS One 8:e58423
Liu KB, Hodes RJ, Weng NP (2001) Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J Immunol 166:4826–4830
Liu JP, Chen SM, Cong YS et al (2010) Regulation of telomerase activity by apparently opposing elements. Ageing Res Rev 9:245–256
Liu P, Zhao H, Luo Y (2017) Anti-aging implications of Astragalus Membranaceus (Huangqi): a well-known Chinese tonic. Aging Dis 8:868–886
Ma L, Chen G, Nie L et al (2009) Effect of Cynomorium songaricum polysaccharide on telomere length in blood and brain of D-galactose-induced senescence mice. Zhongguo Zhong Yao Za Zhi 34:1257–1260
Mattson MP (2000) Emerging neuroprotective strategies for Alzheimer’s disease: dietary restriction, telomerase activation, and stem cell therapy. Exp Gerontol 35:489–502
Mattson MP, Fu W, Zhang P (2001) Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist’s perspective. Mech Ageing Dev 122:659–671
Minamino T, Komuro I (2007) Vascular cell senescence: contribution to atherosclerosis. Circ Res 100:15–26
Molgora B, Bateman R, Sweeney G et al (2013) Functional assessment of pharmacological telomerase activators in human T cells. Cell 2:57–66
Nazari-Shafti TZ, Cooke JP (2015) Telomerase therapy to reverse cardiovascular senescence. Methodist Debakey Cardiovasc J 11:172–175
Njajou OT, Hsueh WC, Blackburn EH et al (2009) Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a population-based cohort study. J Gerontol A Biol Sci Med Sci 64:860–864
Oexle K, Zwirner A (1997) Advanced telomere shortening in respiratory chain disorders. Hum Mol Genet 6:905–908
Oh H, Taffet GE, Youker KA et al (2001) Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci U S A 98:10308–10313
Olovnikov AM (1973) A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 41:181–190
Palm W, de Lange T (2008) How shelterin protects mammalian telomeres. Annu Rev Genet 42:301–334
Pearce VP, Sherrell J, Lou Z et al (2008) Immortalization of epithelial progenitor cells mediated by resveratrol. Oncogene 27:2365–2374
Ren JG, Xia HL, Just T et al (2001) Hydroxyl radical-induced apoptosis in human tumor cells is associated with telomere shortening but not telomerase inhibition and caspase activation. FEBS Lett 488:123–132
Robertson DM et al (2005) Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line. Invest Ophthalmol Vis Sci 46:470–478
Rubio MA, Davalos AR, Campisi J (2004) Telomere length mediates the effects of telomerase on the cellular response to genotoxic stress. Exp Cell Res 298:17–27
Rudolph KL, Chang S, Millard M et al (2000) Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 287:1253–1258
Serrano AL, Andres V (2004) Telomeres and cardiovascular disease: does size matter? Circ Res 94:575–584
Sfeir A, Kosiyatrakul ST, Hockemeyer D et al (2009) Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138:90–103
Shay JW, Wright WE (2000) The use of telomerized cells for tissue engineering. Nat Biotechnol 18:22–23
Shay JW, Wright WE (2007) Hallmarks of telomeres in ageing research. J Pathol 211:114–123
Shay JW, Wright WE (2010) Telomeres and telomerase in normal and cancer stem cells. FEBS Lett 584:3819–3825
Simonsen JL, Rosada C, Serakinci N et al (2002) Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20:592–596
Skulachev VP (1997) Aging is a specific biological function rather than the result of a disorder in complex living systems: biochemical evidence in support of Weismann’s hypothesis. Biochemistry (Mosc) 62:1191–1195
Sone H, Kagawa Y (2005) Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 48:58–67
Stewart SA (2002) Multiple levels of telomerase regulation. Mol Interv 2:481–483
Stewart SA, Bertuch AA (2010) The role of telomeres and telomerase in cancer research. Cancer Res 70:7365–7371
Tichon A, Eitan E, Kurkalli BG et al (2013) Oxidative stress protection by novel telomerase activators in mesenchymal stem cells derived from healthy and diseased individuals. Curr Mol Med 13:1010–1022
Tomas-Loba A, Flores I, Fernández-Marcos PJ et al (2008) Telomerase reverse transcriptase delays aging in cancer-resistant mice. Cell 135:609–622
Townsley DM, Dumitriu B, Liu D et al (2016) Danazol treatment for telomere diseases. N Engl J Med 374:1922–1931
van Steensel B, de Lange T (1997) Control of telomere length by the human telomeric protein TRF1. Nature 385:740–743
van Steensel B, Smogorzewska A, de Lange T (1998) TRF2 protects human telomeres from end-to-end fusions. Cell 92:401–413
Vaughan MB, Ramirez RD, Brown SA et al (2004) A reproducible laser-wounded skin equivalent model to study the effects of aging in vitro. Rejuvenation Res 7:99–110
Venteicher AS, Abreu EB, Meng Z et al (2009) A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science 323:644–648
Villa R, Porta CD, Folini M et al (2001) Possible regulation of telomerase activity by transcription and alternative splicing of telomerase reverse transcriptase in human melanoma. J Invest Dermatol 116:867–873
Weng NP, Granger L, Hodes RJ (1997) Telomere lengthening and telomerase activation during human B cell differentiation. P Natl Acad Sci USA 94:10827–10832
Wright WE, Piatyszek MA, Rainey WE et al (1996) Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18:173–179
Xin HW, Liu D, Wan M et al (2007) TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 445:559–562
Yang C, Przyborski S, Cooke MJ et al (2008) A key role for telomerase reverse transcriptase unit in modulating human embryonic stem cell proliferation, cell cycle dynamics, and in vitro differentiation. Stem Cells 26:850–863
Yi X, White DM, Aisner DL et al (2000) An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia 2:433–440
Yu RA, Chen HJ, He LF et al (2009) Telomerase activity and telomerase reverse transcriptase expression induced by selenium in rat hepatocytes. Biomed Environ Sci 22:311–317
Zhu H, Guo D, Li K et al (2012) Increased telomerase activity and vitamin D supplementation in overweight African Americans. Int J Obes 36:805–809
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Aydin, Y. (2018). Antiaging Strategies Based on Telomerase Activity. In: Rizvi, S., Çakatay, U. (eds) Molecular Basis and Emerging Strategies for Anti-aging Interventions. Springer, Singapore. https://doi.org/10.1007/978-981-13-1699-9_7
Download citation
DOI: https://doi.org/10.1007/978-981-13-1699-9_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1698-2
Online ISBN: 978-981-13-1699-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)